FUJIFILM Company’s Life Sciences Group corporations, a portfolio of companies providing merchandise, providers and complete options that span all phases of therapeutic growth from discovery by means of to commercialization, right now introduced new names and identities as a part of a strategic positioning effort. The Group Corporations’ new names, collaborative strategic focus, and structural alignment displays Fujifilm’s dedication to Life Sciences, providing totally built-in, end-to-end options throughout the drug growth lifecycle—from analysis and discovery to scientific and business manufacturing.
FUJIFILM Irvine Scientific, headquartered in Santa Ana, California rebrands as FUJIFILM Biosciences underneath this new construction and technique. The brand new identify encompasses FUJIFILM Biosciences’ evolution over the previous 55 years – from its formation in 1970 to its current growth to serve broader life sciences communities and clients. It is usually a nod to its scientific roots as a pioneer within the cell tradition media business with a core give attention to innovation and high quality. As we speak, FUJIFILM Biosciences presents a complete portfolio of discovery and analysis reagents, recombinant development components and proteins, specialty chemical compounds, and significant assay supplies along with its strong cell tradition media and dietary supplements options within the U.S. The brand new model identify will take impact instantly, and the authorized entity identify change will likely be efficient January 1, 2026.
FUJIFILM Diosynth Biotechnologies, a number one international contract growth and manufacturing group (CDMO), first acquired by the Fujifilm Group in 2011, rebrands to FUJIFILM Biotechnologies. The Firm serves its international companions providing capabilities for course of growth by means of business provide, with world-class manufacturing operations throughout Europe, and the U.S. The Firm’s authorized identify won’t change.
Over the previous 15 years, Fujifilm has invested over $10 billion by means of expansions and acquisitions to construct its end-to-end life sciences capabilities to create an accelerated path towards higher affected person entry for superior care.
“Underneath the ‘Companions for Life’ umbrella, our Life Sciences Group corporations provide full options to the pharmaceutical and biotechnology markets, aligning with each our strategic development plans and dedication to innovation,” commented Toshihisa Iida, director, company vice chairman, normal supervisor of Life Sciences Technique Headquarters and Bio CDMO Division, FUJIFILM Company, Japan. “By redefining our Life Sciences Group, we additionally assist Fujifilm’s development technique for the life sciences sector, the place we imagine that unifying underneath a single banner will simplify engagement for our international community of shoppers throughout all the product growth and biomanufacturing spectrum. It is a chance to make sure the groups in all our Life Sciences corporations share the identical technique and robust sense of objective. By combining our proprietary applied sciences, reminiscent of AI and sensing, which have been cultivated within the fields of imaging and healthcare, we create new worth and assist pharmaceutical corporations, biotech corporations, and academia in each drug discovery assist options and CDMO providers.”
“FUJIFILM Biosciences focuses on supporting our companions of their life sciences ambitions and doing what we are able to to allow their success alongside the best way,” mentioned Brandon Pence, president and chief working officer, FUJIFILM Biosciences. “Our basis relies upon the core ideas of placing our folks first, remodeling by means of innovation and science, and sustaining a dedication to unprecedented customer support. In doing these issues proper, we create robust relationships, each internally and externally. We’re enthusiastic about this evolution in our enterprise and welcome the chance to develop our constructive influence on clients by means of broader capabilities and collaborating with them on future options.”
At FUJIFILM Biotechnologies, we take immense pleasure within the worth we convey to our companions on a regular basis to assist convey life-changing medicines to sufferers,”
This nearer coordination and united focus strengthens how we work together and ship for our clients. Collectively, we provide deep data and expertise, velocity, flexibility, and scientific rigor—vital parts in bringing advanced biologics to life.”
Lars Petersen, president and chief govt officer, FUJIFILM Biotechnologies
Alongside FUJIFILM Biosciences and FUJIFILM Biotechnologies, the Fujifilm Life Sciences Group corporations additionally embrace FUJIFILM Mobile Dynamics, a number one developer and producer of human induced pluripotent stem cells, FUJIFILM Wako Pure Chemical Company, and FUJIFILM Toyama Chemical Co., Ltd.